vs

Side-by-side financial comparison of Apyx Medical Corp (APYX) and FIRST UNITED CORP (FUNC). Click either name above to swap in a different company.

FIRST UNITED CORP is the larger business by last-quarter revenue ($23.2M vs $19.2M, roughly 1.2× Apyx Medical Corp). FIRST UNITED CORP runs the higher net margin — 24.9% vs -6.8%, a 31.7% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 11.9%). FIRST UNITED CORP produced more free cash flow last quarter ($15.4M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 11.5%).

Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.

United Breweries Holdings Limited (UBHL), also called UB Group, is the Indian subsidiary of Heineken N.V.. It is headquartered in UB City, Bangalore, Karnataka. Its core business includes beverages and investments in various sectors. The company markets beer under the Kingfisher brand, and owns various other brands of alcoholic beverages. United Breweries is India's largest producer of beer.

APYX vs FUNC — Head-to-Head

Bigger by revenue
FUNC
FUNC
1.2× larger
FUNC
$23.2M
$19.2M
APYX
Growing faster (revenue YoY)
APYX
APYX
+22.9% gap
APYX
34.7%
11.9%
FUNC
Higher net margin
FUNC
FUNC
31.7% more per $
FUNC
24.9%
-6.8%
APYX
More free cash flow
FUNC
FUNC
$18.2M more FCF
FUNC
$15.4M
$-2.8M
APYX
Faster 2-yr revenue CAGR
APYX
APYX
Annualised
APYX
36.8%
11.5%
FUNC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
APYX
APYX
FUNC
FUNC
Revenue
$19.2M
$23.2M
Net Profit
$-1.3M
$5.8M
Gross Margin
62.6%
Operating Margin
0.1%
32.9%
Net Margin
-6.8%
24.9%
Revenue YoY
34.7%
11.9%
Net Profit YoY
71.9%
-6.6%
EPS (diluted)
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APYX
APYX
FUNC
FUNC
Q4 25
$19.2M
$23.2M
Q3 25
$12.9M
$22.7M
Q2 25
$11.4M
$21.8M
Q1 25
$9.4M
$20.9M
Q4 24
$14.2M
$20.8M
Q3 24
$11.5M
$20.3M
Q2 24
$12.1M
$20.1M
Q1 24
$10.2M
$18.7M
Net Profit
APYX
APYX
FUNC
FUNC
Q4 25
$-1.3M
$5.8M
Q3 25
$-2.0M
$6.9M
Q2 25
$-3.8M
$6.0M
Q1 25
$-4.2M
$5.8M
Q4 24
$-4.6M
$6.2M
Q3 24
$-4.7M
$5.8M
Q2 24
$-6.6M
$4.9M
Q1 24
$-7.6M
$3.7M
Gross Margin
APYX
APYX
FUNC
FUNC
Q4 25
62.6%
Q3 25
64.4%
Q2 25
62.3%
Q1 25
60.1%
Q4 24
63.0%
Q3 24
60.5%
Q2 24
61.7%
Q1 24
58.1%
Operating Margin
APYX
APYX
FUNC
FUNC
Q4 25
0.1%
32.9%
Q3 25
-6.5%
40.6%
Q2 25
-22.6%
36.5%
Q1 25
-32.4%
36.8%
Q4 24
-21.4%
39.2%
Q3 24
-31.6%
38.0%
Q2 24
-45.7%
32.5%
Q1 24
-64.6%
26.0%
Net Margin
APYX
APYX
FUNC
FUNC
Q4 25
-6.8%
24.9%
Q3 25
-15.4%
30.6%
Q2 25
-33.2%
27.5%
Q1 25
-44.0%
27.7%
Q4 24
-32.5%
29.8%
Q3 24
-40.9%
28.5%
Q2 24
-54.0%
24.5%
Q1 24
-74.0%
19.8%
EPS (diluted)
APYX
APYX
FUNC
FUNC
Q4 25
$0.89
Q3 25
$1.07
Q2 25
$0.92
Q1 25
$0.89
Q4 24
$0.95
Q3 24
$0.89
Q2 24
$-0.19
$0.75
Q1 24
$-0.22
$0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APYX
APYX
FUNC
FUNC
Cash + ST InvestmentsLiquidity on hand
$31.7M
$131.6M
Total DebtLower is stronger
$37.5M
$95.9M
Stockholders' EquityBook value
$14.5M
$203.6M
Total Assets
$66.8M
$2.1B
Debt / EquityLower = less leverage
2.58×
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APYX
APYX
FUNC
FUNC
Q4 25
$31.7M
$131.6M
Q3 25
$25.1M
$95.2M
Q2 25
$29.3M
$79.1M
Q1 25
$31.0M
$84.4M
Q4 24
$31.7M
$78.3M
Q3 24
$28.0M
$62.4M
Q2 24
$32.7M
$45.1M
Q1 24
$37.3M
$86.9M
Total Debt
APYX
APYX
FUNC
FUNC
Q4 25
$37.5M
$95.9M
Q3 25
$37.5M
$95.9M
Q2 25
$37.5M
$120.9M
Q1 25
$37.5M
$120.9M
Q4 24
$37.5M
$120.9M
Q3 24
$37.5M
$120.9M
Q2 24
$70.9M
Q1 24
$70.9M
Stockholders' Equity
APYX
APYX
FUNC
FUNC
Q4 25
$14.5M
$203.6M
Q3 25
$5.8M
$199.1M
Q2 25
$7.3M
$191.1M
Q1 25
$10.5M
$183.7M
Q4 24
$14.2M
$179.3M
Q3 24
$11.0M
$174.0M
Q2 24
$14.7M
$164.2M
Q1 24
$20.3M
$165.5M
Total Assets
APYX
APYX
FUNC
FUNC
Q4 25
$66.8M
$2.1B
Q3 25
$57.4M
$2.0B
Q2 25
$58.2M
$2.0B
Q1 25
$60.2M
$2.0B
Q4 24
$64.8M
$2.0B
Q3 24
$60.7M
$1.9B
Q2 24
$65.4M
$1.9B
Q1 24
$70.7M
$1.9B
Debt / Equity
APYX
APYX
FUNC
FUNC
Q4 25
2.58×
0.47×
Q3 25
6.41×
0.48×
Q2 25
5.17×
0.63×
Q1 25
3.57×
0.66×
Q4 24
2.64×
0.67×
Q3 24
3.40×
0.70×
Q2 24
0.43×
Q1 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APYX
APYX
FUNC
FUNC
Operating Cash FlowLast quarter
$-2.5M
$19.4M
Free Cash FlowOCF − Capex
$-2.8M
$15.4M
FCF MarginFCF / Revenue
-14.6%
66.3%
Capex IntensityCapex / Revenue
1.4%
17.1%
Cash ConversionOCF / Net Profit
3.35×
TTM Free Cash FlowTrailing 4 quarters
$-9.1M
$22.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APYX
APYX
FUNC
FUNC
Q4 25
$-2.5M
$19.4M
Q3 25
$-3.5M
$1.5M
Q2 25
$-1.2M
$995.0K
Q1 25
$-702.0K
$7.0M
Q4 24
$-2.9M
$22.3M
Q3 24
$-4.4M
$2.3M
Q2 24
$-4.3M
$7.2M
Q1 24
$-6.3M
$3.6M
Free Cash Flow
APYX
APYX
FUNC
FUNC
Q4 25
$-2.8M
$15.4M
Q3 25
$-4.1M
$168.0K
Q2 25
$-1.5M
$706.0K
Q1 25
$-757.0K
$6.4M
Q4 24
$-3.2M
$20.4M
Q3 24
$-4.6M
$588.0K
Q2 24
$-4.6M
$7.0M
Q1 24
$-6.4M
$3.5M
FCF Margin
APYX
APYX
FUNC
FUNC
Q4 25
-14.6%
66.3%
Q3 25
-31.5%
0.7%
Q2 25
-13.2%
3.2%
Q1 25
-8.0%
30.5%
Q4 24
-22.4%
98.1%
Q3 24
-40.0%
2.9%
Q2 24
-38.0%
35.1%
Q1 24
-62.2%
18.9%
Capex Intensity
APYX
APYX
FUNC
FUNC
Q4 25
1.4%
17.1%
Q3 25
4.0%
5.9%
Q2 25
2.3%
1.3%
Q1 25
0.6%
2.8%
Q4 24
1.7%
9.3%
Q3 24
1.3%
8.4%
Q2 24
2.4%
0.6%
Q1 24
0.3%
0.3%
Cash Conversion
APYX
APYX
FUNC
FUNC
Q4 25
3.35×
Q3 25
0.22×
Q2 25
0.17×
Q1 25
1.20×
Q4 24
3.60×
Q3 24
0.40×
Q2 24
1.46×
Q1 24
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APYX
APYX

Segment breakdown not available.

FUNC
FUNC

Trust Department$9.8M42%
Other$5.6M24%
Debit Card Income$4.1M17%
Service Charges$2.3M10%
Brokerage Commissions$1.4M6%

Related Comparisons